학술논문
Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis
Document Type
Article
Author
Source
In Pharmacological Research November 2023 197
Subject
Language
ISSN
1043-6618